Please use this identifier to cite or link to this item:
https://doi.org/10.2217/fmb.12.134
Title: | Peptide targeting and imaging of damaged lung tissue in influenza-infected mice | Authors: | Li, N. Yin, L. Thévenin, D. Yamada, Y. Limmon, G. Chen, J. Chow, V.T.K. Engelman, D.M. Engelward, B.P. |
Keywords: | delivery inflammation influenza peptide pHLIP |
Issue Date: | Feb-2013 | Citation: | Li, N., Yin, L., Thévenin, D., Yamada, Y., Limmon, G., Chen, J., Chow, V.T.K., Engelman, D.M., Engelward, B.P. (2013-02). Peptide targeting and imaging of damaged lung tissue in influenza-infected mice. Future Microbiology 8 (2) : 257-269. ScholarBank@NUS Repository. https://doi.org/10.2217/fmb.12.134 | Abstract: | Aim: In this study, we investigate whether pH (low) insertion peptide (pHLIP) can target regions of lung injury associated with influenza infection. Materials & methods: Fluorophore-conjugated pHLIP was injected intraperitoneally into mice infected with a sublethal dose of H1N1 influenza and visualized histologically. Results: pHLIP specifically targeted inflamed lung tissues of infected mice in the later stages of disease and at sites where alveolar type I and type II cells were depleted. Regions of pHLIP-targeted lung tissue were devoid of peroxiredoxin 6, the lung-abundant antioxidant enzyme, and were deficient in pneumocytes. Interestingly, a pHLIP variant possessing mutations that render it insensitive to pH changes was also able to target damaged lung tissue. Conclusion: pHLIP holds potential for delivering therapeutics for lung injury during influenza infection. Furthermore, there may be more than one mechanism that enables pHLIP variants to target inflamed lung tissue. © 2013 Future Medicine Ltd. | Source Title: | Future Microbiology | URI: | http://scholarbank.nus.edu.sg/handle/10635/126745 | ISSN: | 17460913 | DOI: | 10.2217/fmb.12.134 |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.